{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:54:46Z","timestamp":1789206886471,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":964,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.jjcc.2010.08.003","type":"journal-article","created":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T06:29:56Z","timestamp":1284704996000},"page":"115-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Promoter-specific lentivectors for long-term, cardiac-directed therapy of Fabry disease"],"prefix":"10.1016","volume":"57","author":[{"given":"Chyan-Jang","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoXin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Medin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2010.08.003_bib0005","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10545-006-0196-0","article-title":"Manifestations of Fabry disease in placental tissue","volume":"29","author":"Vedder","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-146-6-200703200-00007","article-title":"Narrative review: Fabry disease","volume":"146","author":"Clarke","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0020","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/hrt.2005.063818","article-title":"The heart in Anderson-Fabry disease and other lysosomal storage disorders","volume":"93","author":"Linhart","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0025","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0030","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0035","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/318809","article-title":"A phase 1\/2 clinical trial of enzyme replacement in Fabry disease: pharmacokinetic, substrate clearance, and safety studies","volume":"68","author":"Eng","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2014replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/hrt.2006.104026","article-title":"Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa","volume":"94","author":"Hughes","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0050","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/j.1523-1755.2004.00924.x","article-title":"Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and beta","volume":"66","author":"Linthorst","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2008.10.004","article-title":"A retrospective analysis of the potential impact of IgG antibodies to agalsidase beta on efficacy during enzyme replacement therapy for Fabry disease","volume":"96","author":"Benichou","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/422366","article-title":"Long-term safety and efficacy of enzyme replacement therapy for Fabry disease","volume":"75","author":"Wilcox","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"Suppl. 2","key":"10.1016\/j.jjcc.2010.08.003_bib0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1012455421014","article-title":"Gene therapy for Fabry disease","volume":"24","author":"Siatskas","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0070","doi-asserted-by":"crossref","first-page":"16909","DOI":"10.1073\/pnas.0407572101","article-title":"Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors","volume":"101","author":"Yoshimitsu","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.gt.3302839","article-title":"Efficient correction of Fabry mice and patient cells mediated by lentiviral transduction of hematopoietic stem\/progenitor cells","volume":"14","author":"Yoshimitsu","year":"2007","journal-title":"Gene Ther"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0080","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1253\/circj.70.1503","article-title":"Correction of cardiac abnormalities in Fabry mice by direct intraventricular injection of a recombinant lentiviral vector that engineers expression of alpha-galactosidase A","volume":"70","author":"Yoshimitsu","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0085","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1128\/JVI.76.7.3558-3563.2002","article-title":"Redirecting retroviral tropism by insertion of short, nondisruptive peptide ligands into envelope","volume":"76","author":"Gollan","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0090","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1089\/10430340050015437","article-title":"A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display","volume":"11","author":"Fielding","year":"2000","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0095","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1089\/hum.2008.189","article-title":"Single-chain antibodies that target lentiviral vectors to MHC class II on antigen-presenting cells","volume":"20","author":"Gennari","year":"2009","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0100","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2009-05-220798","article-title":"Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors","volume":"114","author":"Frecha","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/85664","article-title":"Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo","volume":"19","author":"Kobinger","year":"2001","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nbt1049","article-title":"Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters","volume":"23","author":"Amendola","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0115","doi-asserted-by":"crossref","first-page":"9180","DOI":"10.1016\/S0021-9258(18)31568-0","article-title":"Isolation and characterization of the mouse cardiac myosin heavy chain genes","volume":"266","author":"Gulick","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0120","doi-asserted-by":"crossref","first-page":"16280","DOI":"10.1073\/pnas.0407449101","article-title":"Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts","volume":"101","author":"Su","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0125","doi-asserted-by":"crossref","first-page":"30595","DOI":"10.1016\/S0021-9258(18)43855-0","article-title":"Characterization of cis-regulating elements and trans-activating factors of the rat cardiac troponin T gene","volume":"269","author":"Wang","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jjcc.2009.05.010","article-title":"Vascular endothelial growth factor broadens lentivector distribution in the heart after neonatal injection","volume":"54","author":"Sato","year":"2009","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0135","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ymthe.2006.05.010","article-title":"Identification and isolation of embryonic stem cell-derived target cells by adenoviral conditional targeting","volume":"14","author":"Takahashi","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jgm.1122","article-title":"Human CMV immediate-early enhancer: a useful tool to enhance cell-type-specific expression from lentiviral vectors","volume":"10","author":"Gruh","year":"2008","journal-title":"J Gene Med"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0145","doi-asserted-by":"crossref","first-page":"24613","DOI":"10.1016\/S0021-9258(18)54273-3","article-title":"Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice","volume":"266","author":"Subramaniam","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0150","first-page":"1220","article-title":"Positive regulatory elements (HF-1a and HF-1b) and a novel negative regulatory element (HF-3) mediate ventricular muscle-specific expression of myosin light-chain 2-luciferase fusion genes in transgenic mice","volume":"14","author":"Lee","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0155","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/nar\/gkh327","article-title":"Myosin light chain 1 atrial isoform (MLC1A) is expressed in pre-B cells under control of the BOB.1\/OBF.1 coactivator","volume":"32","author":"Laumen","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0160","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ar.20772","article-title":"Requirement of TCTG(G\/C) direct repeats and overlapping GATA site for maintaining the cardiac-specific expression of cardiac troponin T in developing and adult mice","volume":"291","author":"Harlan","year":"2008","journal-title":"Anat Rec (Hoboken)"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/sj.gt.3302126","article-title":"CMV enhancer\/human PDGF-beta promoter for neuron-specific transgene expression","volume":"11","author":"Liu","year":"2004","journal-title":"Gene Ther"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0170","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.6823562","article-title":"Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid","volume":"219","author":"Senger","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.jjcc.2010.08.003_bib0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1537-1891(03)00011-9","article-title":"Regulation of vascular permeability by vascular endothelial growth factors","volume":"39","author":"Bates","year":"2002","journal-title":"Vascul Pharmacol"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450871000170X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450871000170X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:48:44Z","timestamp":1760273324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S091450871000170X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S091450871000170X"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2010.08.003","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promoter-specific lentivectors for long-term, cardiac-directed therapy of Fabry disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2010.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}